Legend Biotech Corporation Revenue per Employee (LEGN), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Legend Biotech Corporation  (NASDAQ: LEGN)
 

Legend Biotech's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 451.62% in the fourth quarter 2025, year on year to cumulative value of $1,751 million, Legend Biotech's revenue per employee grew on a trailing twelve months basis to $ 603,911. The productivity of Legend Biotech's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 297 other companies have achieved higher revenue per employee. While Legend Biotech's total ranking has deteriorated compared to the previous quarter from 0 to 2404. Legend Biotech has 2,900 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

LEGN Revenue per Employee (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Revenue Change 451.62 % 69.99 % 36.74 % 107.52 % -34.59 %
Sales per Employee (TTM) $ 603,911 313,436 274,772 251,139 216,290
LEGN's Total Ranking # 2404 # 0 # # #
Seq. Revenue Change 277.81 % 6.77 % 30.76 % 4.57 % 16.43 %

LEGN Company Profile >> Back to LEGN Efficiency Comparisons >> Compare LEGN Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 146
Healthcare Sector # 298
Overall Market # 2404

Revenue per Employee Statistics
High Average Low
$ 354,793 $ 145,293 $ 26,095
(Dec 31 2025)   (Dec 31 2020)



Financial Statements
Legend Biotech's Revenue MRQ $ 1,029 Millions Visit LEGN's Income Statement
Legend Biotech's Revenues TTM $ 1,751 Millions Visit LEGN's aggregate revenue growth
What are LEGN's Sales? Visit LEGN's Sales by Segment




Other Ratios
Legend Biotech's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
LEGN's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for LEGN's Competitors
Revenue per Employee for LEGN's Suppliers
Revenue per Employee for LEGN's Customers

You may also want to know
LEGN's Sales Growth Rates LEGN's Pe Price to earnings ratio LEGN's Receivables Turnover Ratio LEGN's Stock Quote
LEGN's Net Income Growth Rates LEGN's Ps Price to Sales ratio LEGN's Sales per Employee LEGN's Asset Turnover Ratio
LEGN's Net Margin LEGN's Pb Price to Book ratio LEGN's Financial Strength Ratios LEGN's Dividend Payout Ratio
Date modified: 2026-09-08T18:38:39+00:00




Companies with similar Revenue per Employee for 12 months ending Dec 31 2025, within Healthcare Sector Revenue per Employee Revenue 12 months ending Dec 31 2025Number of Employees Dec 31 2025
Madrigal Pharmaceuticals Inc   1,047,434.97 $ 958.403  Million 915 
Corcept Therapeutics Inc  1,043,023.29 $ 761.407  Million 730 
Integrated Biopharma Inc  1,021,360.00 $ 51.068  Million 50 
Biomarin Pharmaceutical Inc  1,000,078.55 $ 3,221.253  Million 3,221 
Coya Therapeutics Inc   993,219.13 $ 7.946  Million 8 
Assembly Biosciences Inc   990,452.05 $ 72.303  Million 73 
Travere Therapeutics Inc   987,380.28 $ 490.728  Million 497 
Hims and Hers Health Inc   961,252.25 $ 2,347.378  Million 2,442 
Sanara Medtech Inc   949,972.34 $ 102.597  Million 108 
Cue Biopharma Inc   947,103.45 $ 27.466  Million 29 
Lifevantage Corp  934,533.63 $ 208.401  Million 223 
Regeneron Pharmaceuticals Inc   930,752.76 $ 14,342.900  Million 15,410 
Ani Pharmaceuticals Inc  910,686.60 $ 883.366  Million 970 
Keenova Therapeutics Plc  906,562.50 $ 1,450.500  Million 1,600 
Scilex Holding Company  889,794.12 $ 30.253  Million 34 
Evolus Inc   889,541.92 $ 297.107  Million 334 
Day One Biopharmaceuticals Inc   888,662.92 $ 158.182  Million 178 
Xtant Medical Holdings Inc   882,602.65 $ 133.273  Million 151 
Nektar Therapeutics  876,698.41 $ 55.232  Million 63 
Pacira Biosciences inc   876,249.70 $ 726.411  Million 829 
Merck and Co Inc   866,813.33 $ 65,011.000  Million 75,000 
Carlisle Companies Incorporated  850,830.51 $ 5,019.900  Million 5,900 
Alphatec Holdings Inc   836,679.08 $ 763.888  Million 913 
Pfizer Inc  834,386.67 $ 62,579.000  Million 75,000 
Ardelyx inc   832,965.24 $ 407.320  Million 489 
Emergent Biosolutions Inc   825,444.44 $ 742.900  Million 900 
Monte Rosa Therapeutics Inc   824,480.00 $ 123.672  Million 150 
Fortress Biotech Inc   811,051.28 $ 63.262  Million 78 
Sanuwave Health Inc   800,927.27 $ 44.051  Million 55 
Adma Biologics Inc   785,336.94 $ 508.113  Million 647 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.